Description:

Serious Adverse Event Form (Form 24-SAE_B) Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B0EA7BE0-EB0F-636A-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B0EA7BE0-EB0F-636A-E034-0003BA12F5E7

Keywords:
Versions (2) ▾
  1. 8/27/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00659373 Toxicity - Serious Adverse Event Form (Form 24-SAE_B) - 2074086v3.0

No Instruction available.

  1. StudyEvent: Serious Adverse Event Form (Form 24-SAE_B)
    1. No Instruction available.
Section B - Follow-up Report
Action taken regarding protocol treatment: (select all that apply)
Were there changes in previous Concomitant Therapy? (Complete ONLY if different from initial report in Section A.)
Outcome (select one)
Autopsy Report available?
Ccrr Module For Serious Adverse Event Form (form 24-sae_b)

Similar models